Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Folinic Acid Intervention for ASD: Links to Folate Receptor-alpha Autoimmunity & Redox Metabolism

NCT01602016 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT01602016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01602016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Folinic Acid Intervention for ASD: Links to Folate Receptor-alpha Autoimmunity & Redox Metabolism
Lead sponsor
University of Arkansas
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2012
Completion date
November 30, 2015
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asperger's syndrome, autism, autism spectrum disorder, autistic disorder, pervasive development disorders